Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Joseph Pantginis downgraded the rating for Astria Therapeutics Inc (NASDAQ:ATXS) from Buy to Neutral. Astria Therapeutics shares closed at $11.92 on Wednesday. See how other analysts view this stock.
- B of A Securities analyst Julien Dumoulin-Smith downgraded Atmos Energy Corp (NYSE:ATO) from Buy to Neutral …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Joseph Pantginis downgraded the rating for Astria Therapeutics Inc (NASDAQ:ATXS) from Buy to Neutral. Astria Therapeutics shares closed at $11.92 on Wednesday. See how other analysts view this stock.
- B of A Securities analyst Julien Dumoulin-Smith downgraded Atmos Energy Corp (NYSE:ATO) from Buy to Neutral …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
HC Wainwright & Co. analyst Joseph Pantginis downgraded the rating for Astria Therapeutics Inc (NASDAQ:ATXS) from Buy to Neutral. Astria Therapeutics shares closed at $11.92 on Wednesday. See how other analysts view this stock.
B of A Securities analyst Julien Dumoulin-Smith downgraded Atmos Energy Corp (NYSE:ATO) from Buy to Neutral …Full story available on Benzinga.com Read MoreATO, ATXS, FHN, News, Top Downgrades, VRSK, XMTR, Downgrades, Markets, Analyst Ratings, Trading Ideas, ATO, US0495601058, FHN, US3205171057, VRSK, US92345Y1064, XMTR, ATXS, News, Downgrades, Markets, Analyst Ratings, Trading Ideas, Benzinga News
